메뉴 건너뛰기




Volumn 15, Issue 2, 2009, Pages 61-64

Screening and treatment of glucocorticoid-induced osteoporosis in rheumatoid arthritis patients in an urban multispecialty practice

Author keywords

Glucorticoid induced osteoporosis; Rheumatoid arthritis; Urban multispecialty practice

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; CALCIUM; GLUCOCORTICOID; VITAMIN D; BONE DENSITY CONSERVATION AGENT;

EID: 67449085324     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/RHU.0b013e31819b65bd     Document Type: Article
Times cited : (15)

References (18)
  • 1
    • 0141993640 scopus 로고    scopus 로고
    • Bone mineral density measurement and treatment for osteoporosis in older individuals with fractures-a gap in evidence based practice guideline implementation
    • Feldstien A, Elmer PJ, Orwoll R, et al. Bone mineral density measurement and treatment for osteoporosis in older individuals with fractures-a gap in evidence based practice guideline implementation. Arch Intern Med. 2003; 163:2165-2172.
    • (2003) Arch Intern Med , vol.163 , pp. 2165-2172
    • Feldstien, A.1    Elmer, P.J.2    Orwoll, R.3
  • 2
    • 2442659209 scopus 로고    scopus 로고
    • Osteoporosis screening: Time to take responsibility
    • Mazanec D. Osteoporosis screening: time to take responsibility. Arch Intern Med. 2004;164:1047-1048.
    • (2004) Arch Intern Med , vol.164 , pp. 1047-1048
    • Mazanec, D.1
  • 3
    • 0037129560 scopus 로고    scopus 로고
    • Epidemiology and outcomes of osteoporotic fractures
    • Cummings SR, Melton LJ. Epidemiology and outcomes of osteoporotic fractures. Lancet. 2002;59:1761-1767.
    • (2002) Lancet , vol.59 , pp. 1761-1767
    • Cummings, S.R.1    Melton, L.J.2
  • 4
    • 33749510518 scopus 로고    scopus 로고
    • Prevalence of evaluation and treatment of glucocorticoid-induced osteoporosis in men
    • Cruse LM, Valeriano J, Vasey FB, et al. Prevalence of evaluation and treatment of glucocorticoid-induced osteoporosis in men. JCR- J Clin Rheumatol. 2006;12:221-225.
    • (2006) JCR- J Clin Rheumatol , vol.12 , pp. 221-225
    • Cruse, L.M.1    Valeriano, J.2    Vasey, F.B.3
  • 5
    • 0029787602 scopus 로고    scopus 로고
    • Use of oral cocorticosteroids in the community and the prevention of secondary osteoporosis: A cross sectional study
    • Walsh L, Wong C, Pringle M, et al. Use of oral cocorticosteroids in the community and the prevention of secondary osteoporosis: a cross sectional study. Br Med J. 1996;313:344-346.
    • (1996) Br Med J , vol.313 , pp. 344-346
    • Walsh, L.1    Wong, C.2    Pringle, M.3
  • 6
    • 0028874264 scopus 로고
    • Rheumatoid arthritis, corticosteroid therapy, and the risk of hip fracture
    • Cooper C, Coupland C, Mitchell M. Rheumatoid arthritis, corticosteroid therapy, and the risk of hip fracture. Ann Rheum Dis. 1995;54:49-52.
    • (1995) Ann Rheum Dis , vol.54 , pp. 49-52
    • Cooper, C.1    Coupland, C.2    Mitchell, M.3
  • 7
    • 26044472191 scopus 로고    scopus 로고
    • Glucocorticoid-induced osteoporosis: Treatment options and guidelines
    • Marici M. Glucocorticoid-induced osteoporosis: treatment options and guidelines. Curr Osteoporos Rep. 2005;3:25-29.
    • (2005) Curr Osteoporos Rep , vol.3 , pp. 25-29
    • Marici, M.1
  • 8
    • 0346749741 scopus 로고    scopus 로고
    • Glucocorticoid induced osteoporosis
    • Compston J. Glucocorticoid induced osteoporosis. Horm Res. 2003;l60: 77-79.
    • (2003) Horm Res
    • Compston, J.1
  • 9
    • 0034924611 scopus 로고    scopus 로고
    • Prevention of glucocorticoid-induced Osteoporosis
    • Yood R, Leslie H, Fish L, et al. Prevention of glucocorticoid-induced Osteoporosis. Arch Intern Med. 2001;161:1322-1327.
    • (2001) Arch Intern Med , vol.161 , pp. 1322-1327
    • Yood, R.1    Leslie, H.2    Fish, L.3
  • 10
    • 0033768877 scopus 로고    scopus 로고
    • Glucocorticoid-induced osteoporosis: Pathogenesis and management
    • Nishimura J, Ikuyama S. Glucocorticoid-induced osteoporosis: pathogenesis and management. J Bone Miner Metab. 2000;18:350-352.
    • (2000) J Bone Miner Metab , vol.18 , pp. 350-352
    • Nishimura, J.1    Ikuyama, S.2
  • 11
    • 0029864560 scopus 로고    scopus 로고
    • Recommendations for the prevention and treatment of glucocorticoid- induced osteoporosis. American college of rheumatology task force on osteoporosis guidelines
    • Recommendations for the prevention and treatment of glucocorticoid- induced osteoporosis. American college of rheumatology task force on osteoporosis guidelines. Arthritis Rheum. 1996;39:1791-1801.
    • (1996) Arthritis Rheum , vol.39 , pp. 1791-1801
  • 12
    • 0036898723 scopus 로고    scopus 로고
    • Management of glucocorticoid- induced osteoporosis in patients with rheumatoid arthritis
    • Solomon DH, Katz J, Jacobs JP, et al. Management of glucocorticoid- induced osteoporosis in patients with rheumatoid arthritis. Arthritis Rheum. 2002;46: 3136-3142.
    • (2002) Arthritis Rheum , vol.46 , pp. 3136-3142
    • Solomon, D.H.1    Katz, J.2    Jacobs, J.P.3
  • 13
    • 0031816610 scopus 로고    scopus 로고
    • Should we look for osteoporosis in patients with rheumatoid arthritis?
    • Lems WF, Dijkmans BA. Should we look for osteoporosis in patients with rheumatoid arthritis? Ann Rheum Dis. 1998;57:325-327.
    • (1998) Ann Rheum Dis , vol.57 , pp. 325-327
    • Lems, W.F.1    Dijkmans, B.A.2
  • 14
    • 0034944221 scopus 로고    scopus 로고
    • Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update
    • American College Of Rheumatology Ad Hoc Committee On Glucocorticoid- Induced Osteoporosis
    • American College Of Rheumatology Ad Hoc Committee On Glucocorticoid- Induced Osteoporosis. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. Arthritis Rheum. 2001;44:1496-1503.
    • (2001) Arthritis Rheum , vol.44 , pp. 1496-1503
  • 15
    • 34047237367 scopus 로고    scopus 로고
    • Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause
    • Rossouw JE, Prentice RL, Manson JE, et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA. 2007;297:1465-1477.
    • (2007) JAMA , vol.297 , pp. 1465-1477
    • Rossouw, J.E.1    Prentice, R.L.2    Manson, J.E.3
  • 16
    • 0345060379 scopus 로고    scopus 로고
    • Older women with fractures: Patients falling through the cracks of guideline-recommended osteoporosis screening and treatment
    • Feldstein A, Nichols G, Elmer P, et al. Older women with fractures: patients falling through the cracks of guideline-recommended osteoporosis screening and treatment. J Bone Joint Surg Am. 2003;85:2294-2302.
    • (2003) J Bone Joint Surg Am , vol.85 , pp. 2294-2302
    • Feldstein, A.1    Nichols, G.2    Elmer, P.3
  • 17
    • 0037330837 scopus 로고    scopus 로고
    • Glucocorticoid-induced osteoporosis: Pathogenesis, diagnosis, and management
    • McIlwain HH. Glucocorticoid-induced osteoporosis: pathogenesis, diagnosis, and management. Prev Med. 2003;36:243-249.
    • (2003) Prev Med , vol.36 , pp. 243-249
    • McIlwain, H.H.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.